THE GOOD NEWS
The FDA has approved a new drug for treating the terrible suffering caused when breast or prostate cancer spreads to the bone. Called Metastron, the drug kills the pain of the cancer (though not the cancer) with radioactive strontium-89 delivered by injection. Metastron works better than narcotics for many patients, and a single shot lasts up to six months.
Researchers in Germany and the U.S. think they're homing in on a cause of dyslexia, the brain abnormality that makes language processing -- especially reading the printed word -- difficult for about 3% of the population. At least some...
To continue reading:
or
Log-In
